Safety and Efficacy of Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease in a Four-Week Double-blind, Placebo-controlled Randomized Crossover Study (P3.8-036)

作者：Aleksandar Videnović, Amy W. Amara, Cynthia L. Comella, Paula K. Schweitzer, Hélène A. Emsellem, Kris Liu, Amanda Sterkel, Mildred D. Gottwald, Joshua R. Steinerman, Philip Jochelson, Robert A. Hauser · 发表于：Neurology · 年份：2019 · DOI：10.1212/wnl.92.15_supplement.p3.8-036 · 研究领域：Parkinson's Disease Mechanisms and Treatments、Sleep and Wakefulness Research

To evaluate the safety (primary objective) and efficacy of solriamfetol for the treatment of excessive daytime sleepiness (EDS) in participants with Parkinson’s Disease (PD).